Cargando…
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis
Liver fibrosis is characterized by changes in tissue architecture and extracellular matrix composition. Liver fibrosis affects not only hepatocytes but also the non-parenchymal cells such as hepatic stellate cells (HSCs), which are essential for maintaining an intact liver structure and function. Tr...
Autores principales: | Kim, Jung-Yeon, An, Hyun-Jin, Kim, Woon-Hae, Gwon, Mi-Gyeong, Gu, Hyemin, Park, Yoon-Yub, Park, Kwan-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511593/ https://www.ncbi.nlm.nih.gov/pubmed/28918026 http://dx.doi.org/10.1016/j.omtn.2017.06.022 |
Ejemplares similares
-
Antifibrotic Effect of Smad Decoy Oligodeoxynucleotide in a CCl(4)-Induced Hepatic Fibrosis Animal Model
por: Gwon, Mi-Gyeong, et al.
Publicado: (2018) -
Anti-Fibrotic Effect of Synthetic Noncoding Oligodeoxynucleotide for Inhibiting mTOR and STAT3 via the Regulation of Autophagy in an Animal Model of Renal Injury
por: Jung, Hyun Jin, et al.
Publicado: (2022) -
Beneficial Effects of SREBP Decoy Oligodeoxynucleotide in an Animal Model of Hyperlipidemia
por: An, Hyun-Jin, et al.
Publicado: (2020) -
The Effects of Synthetic SREBP-1 and PPAR-γ Decoy Oligodeoxynucleotide on Acne-like Disease In Vivo and In Vitro via Lipogenic Regulation
por: Gu, Hyemin, et al.
Publicado: (2022) -
The decoy oligodeoxynucleotide against HIF-1α and STAT5 ameliorates atopic dermatitis-like mouse model
por: Gwon, Mi-Gyeong, et al.
Publicado: (2023)